Format

Send to

Choose Destination
Eur J Heart Fail. 2019 Jun;21(6):818. doi: 10.1002/ejhf.1446. Epub 2019 Feb 27.

Letter on 'Idarucizumab for the reversal of dabigatran in patients undergoing heart transplantation'.

Author information

1
Department of Cardiology, Montpellier University Hospital, Montpellier, France.
2
Department of Anesthesiology and Critical Care Medicine, PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU de Montpellier, Montpellier, France.
3
Cardiology Department, PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU de Montpellier, Montpellier, France.
PMID:
30815956
DOI:
10.1002/ejhf.1446

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center